Healthcare provider profile · identity verified

Michael George Baltes, MD

Family Practice · SAINT LOUIS, MO · NPI 1104317643

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	574	99
Levothyroxine Sodium	Levothyroxine Sodium	349	53
Lisinopril	Lisinopril	328	46
Bupropion Xl	Bupropion Hcl	282	42
Metformin Hcl Er	Metformin Hcl	263	46
Topiramate	Topiramate	246	49
Gabapentin	Gabapentin	239	39
Famotidine	Famotidine	219	43
Pantoprazole Sodium	Pantoprazole Sodium	207	34
Trazodone Hcl	Trazodone Hcl	194	30
Duloxetine Hcl	Duloxetine Hcl	185	30
Omeprazole	Omeprazole	185	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	168	23
Tamsulosin Hcl	Tamsulosin Hcl	164	29
Metformin Hcl	Metformin Hcl	150	27
Albuterol Sulfate Hfa	Albuterol Sulfate	139	33
Clopidogrel	Clopidogrel Bisulfate	136	19
Hydroxyzine Hcl	Hydroxyzine Hcl	135	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	128	24
Meloxicam	Meloxicam	125	26
Trulicity	Dulaglutide	124	18
Metoprolol Tartrate	Metoprolol Tartrate	121	13
Amlodipine Besylate	Amlodipine Besylate	120	27
Chlorthalidone	Chlorthalidone	118	19
Ozempic	Semaglutide	109	20
Propranolol Hcl	Propranolol Hcl	108	17
Rosuvastatin Calcium	Rosuvastatin Calcium	103	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	102	17
Losartan Potassium	Losartan Potassium	102	19
Tramadol Hcl	Tramadol Hcl	102	16
Pravastatin Sodium	Pravastatin Sodium	101	17
Jardiance	Empagliflozin	99	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	99	11
Buspirone Hcl	Buspirone Hcl	94	19
Metoprolol Succinate	Metoprolol Succinate	94	23
Simvastatin	Simvastatin	93	15
Amitriptyline Hcl	Amitriptyline Hcl	91	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	88	15
Fluoxetine Hcl	Fluoxetine Hcl	85	17
Tizanidine Hcl	Tizanidine Hcl	84	16
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	83	12
Pregabalin	Pregabalin	80	14
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	77	16
Furosemide	Furosemide	71	15
Carvedilol	Carvedilol	69	suppressed
Sertraline Hcl	Sertraline Hcl	69	12
Escitalopram Oxalate	Escitalopram Oxalate	65	15
Potassium Chloride	Potassium Chloride	65	11
Fluticasone Propionate	Fluticasone Propionate	63	29
Venlafaxine Hcl Er	Venlafaxine Hcl	63	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	60	suppressed
Mirtazapine	Mirtazapine	55	12
Naltrexone Hcl	Naltrexone Hcl	55	11
Allopurinol	Allopurinol	54	11
Arexvy	Rsvpref3 Antigen/As01e/Pf	51	51
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	50	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	suppressed
Farxiga	Dapagliflozin Propanediol	49	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	46	11
Hydrochlorothiazide	Hydrochlorothiazide	45	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	44	suppressed
Ropinirole Hcl	Ropinirole Hcl	44	suppressed
Symbicort	Budesonide/Formoterol Fumarate	44	suppressed
Eliquis	Apixaban	43	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	42	suppressed
Diazepam	Diazepam	41	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	40	suppressed
Alprazolam	Alprazolam	39	suppressed
Xarelto	Rivaroxaban	38	suppressed
Celecoxib	Celecoxib	37	suppressed
Invokana	Canagliflozin	37	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	37	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Januvia	Sitagliptin Phosphate	34	suppressed
Breo Ellipta	Fluticasone/Vilanterol	32	suppressed
Fenofibrate	Fenofibrate	31	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	31	suppressed
Levetiracetam	Levetiracetam	30	suppressed
Spironolactone	Spironolactone	30	suppressed
Clonazepam	Clonazepam	29	suppressed
Meclizine Hcl	Meclizine Hcl	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Lorazepam	Lorazepam	28	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Prazosin Hcl	Prazosin Hcl	27	suppressed
Ventolin Hfa	Albuterol Sulfate	27	suppressed
Bupropion Hcl Sr	Bupropion Hcl	26	suppressed
Levemir Flexpen	Insulin Detemir	25	suppressed
Irbesartan	Irbesartan	24	suppressed
Rexulti	Brexpiprazole	24	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	23	suppressed
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Vraylar	Cariprazine Hcl	22	suppressed
Fentanyl	Fentanyl	21	suppressed
Incruse Ellipta	Umeclidinium Bromide	21	suppressed
Spiriva Handihaler	Tiotropium Bromide	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Finasteride	Finasteride	19	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	18	suppressed
Telmisartan	Telmisartan	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	17	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Naproxen	Naproxen	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	15	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Ramelteon	Ramelteon	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Synjardy	Empagliflozin/Metformin Hcl	15	suppressed
Famciclovir	Famciclovir	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Valsartan	Valsartan	14	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Clozapine	Clozapine	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Estradiol	Estradiol	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Metformin Er Osmotic	Metformin Hcl	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Otezla	Apremilast	12	suppressed
Prednisone	Prednisone	12	suppressed
Trulance	Plecanatide	12	suppressed
Ultiguard Safepack-Pen Needle	Pen Needle, Diabetic,disp Unit	12	suppressed
Atenolol	Atenolol	11	suppressed
Clonidine	Clonidine	11	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	11	suppressed
Techlite Pen Needle	Pen Needle, Diabetic	11	suppressed
Zubsolv	Buprenorphine Hcl/Naloxone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error